Tech Company Financing Transactions
Truveris Funding Round
On 9/7/2017, Truveris raised $25 million in Series D funding from McKesson Ventures, Canaan Partners and New Atlantic Ventures.
Transaction Overview
Company Name
Announced On
9/7/2017
Transaction Type
Venture Equity
Venture Equity
Venture Equity
Amount
$25,000,000
Round
Series D
Investors
McKesson Ventures (Lead Investor) (Tom Rodgers)
Proceeds Purpose
This strategic investment enables us to rapidly expand the availability of our platform so we can help more organizations reduce costs and improve access to medications.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
2 Park Ave. 1500
New York, NY 10016
USA
New York, NY 10016
USA
Phone
Website
Email Address
Not Recorded
Overview
Truveris is a health information technology company that provides management tools to sponsors of prescription benefit plans and payers of claims under these plans.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Faisal Mushtaq
Chief Financial Officer
Michael Facendola
VP - Engineering
Bertrand Janin
VP - Marketing
A.J. Loiacono
VP - Product Management
Puneet Goel
VP - Sales
Kristin Begley
Browse more venture capital transactions:
Prev: 9/7/2017: Orion Labs venture capital transaction
Next: 9/7/2017: Dataiku venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs